Skip to content

Clinical trials

Recruiting Diabetes Mellitus, Type 2 trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Diabetes Mellitus, Type 2 Status: Recruiting Country / region: United States Clear all

247 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20141
20181
20196
20202
20216
202214
202327
202446
202557
202687

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting247

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca10
Novo Nordisk A/S8
The University of Texas Health Science Center at San Antonio8
Ohio State University7
Stanford University6
Eli Lilly and Company4
Massachusetts General Hospital4
Medical College of Wisconsin4
Rutgers, The State University of New Jersey4
San Diego State University4

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Diabetes Mellitus, Type 2247
Obesity53
Diabetes Mellitus40
Overweight27
Diabetes Mellitus, Type 122
Insulin Resistance19
Prediabetic State19
Cardiovascular Diseases12
Hypertension12
Renal Insufficiency, Chronic11

Trials

Showing 1 to 25 of 247. Each trial links to its page on Pharma Observatory.

147 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.